Zoetis (ZTS) CEO awarded 28,072 RSUs and 111,060 stock options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
PECK KRISTIN C reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. reported that Chief Executive Officer Kristin C. Peck received new equity awards. On February 18, 2026, she was granted 28,072 restricted stock units (RSUs) and 111,060 stock options at no cost, as compensation awards.
Each RSU represents a contingent right to one share of Zoetis common stock and, according to the plan terms, one-third of each RSU and one-third of each option will vest on the first, second, and third anniversaries of the February 18, 2026 grant date, subject to continued service and certain earlier vesting events. The options expire on the tenth anniversary of the grant date.
Positive
- None.
Negative
- None.
Insider Trade Summary
8 transactions reported
Mixed
8 txns
Insider
PECK KRISTIN C
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Unit | 28,072 | $0.00 | -- |
| Grant/Award | Stock Option | 111,060 | $0.00 | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Unit — 28,072 shares (Direct);
Stock Option — 111,060 shares (Direct)
Footnotes (1)
- Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 18, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Not applicable. One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 19, 2025; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. One-third of each RSU vests and is settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 6, 2024; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan. One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 18, 2026. Each option expires on the tenth anniversary of the date of grant. One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 19, 2025. One-third of each option vests on the first, second and third anniversaries of the date of grant, February 6, 2024. One-third of each option vested on the first, second and third anniversaries of the date of grant, February 8, 2023. Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option; 61,078 options granted February 10, 2021 at an exercise price of $160.62 per option; and 54,751 options granted February 8, 2022 at an exercise price of $201.30 per option. Each option vested on the third anniversary of the date of grant.
FAQ
What did Zoetis (ZTS) CEO Kristin Peck report in this Form 4?
Kristin Peck reported receiving new equity awards from Zoetis Inc. The filing shows grants of 28,072 restricted stock units and 111,060 stock options on February 18, 2026, as part of compensation under the company’s equity and incentive plan.
How many restricted stock units did Zoetis (ZTS) grant to its CEO?
Zoetis granted Kristin Peck 28,072 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Zoetis common stock, aligning the CEO’s compensation with future company performance and shareholder value over time.
How many stock options were granted to the Zoetis (ZTS) CEO in this filing?
The Form 4 shows a grant of 111,060 stock options to Kristin Peck. These options were issued under the Zoetis Amended and Restated 2013 Equity and Incentive Plan as part of her long-term, equity-based compensation package.
What is the vesting schedule for the new Zoetis (ZTS) RSU grant?
One-third of each RSU will vest and be settled in Zoetis common shares on the first, second, and third anniversaries of the February 18, 2026 grant date, provided Kristin Peck continues in service or meets specified earlier vesting conditions.
When do the newly granted Zoetis (ZTS) stock options vest and expire?
One-third of each stock option will vest on the first, second, and third anniversaries of the February 18, 2026 grant date. Each option expires on the tenth anniversary of that grant date, if not exercised or forfeited earlier under plan terms.
What plan governs the equity awards reported in this Zoetis (ZTS) Form 4?
The RSUs and stock options were granted under the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan. This plan provides for stock-based compensation, including restricted stock units, dividend equivalents, and stock options for eligible participants.